Subdued market sentiment and disappointing fourth quarter results pulled Aurobindo Pharma down 3.70 per cent in today's trading. The stock in intra-day trades touched a low of Rs 346 before closing at Rs 359.60. |
The counter witnessed volumes of more than 59 thousand shares at the BSE and 1.88 lakh shares at the NSE. Analysts said, disappointing Q4 results propelled selling by market participants. |
The company for the quarter ended March 31 reported a decline in net profit at Rs 36.22 crore as against Rs 46.37 crore in the same period last year. |
The counter was also under selling pressure on overall weakness in the market sentiment as investors are looking at exit options at every higher levels. |
For the year ended March 31, the company's net profit stood at Rs 127.01 crore as against Rs 103.14 crore on total income of Rs 1,363.13 crore. |